|
| |
Neuroendocrine TumorsDownload PDF containing detailed information.
Recent Publications on Neuroendocrine Tumors: |  |
Compound heterozygous mutation with a novel splice donor region DNA sequence variant in the succinate dehydrogenase subunit B gene in malignant paraganglioma.
Pheochromocytoma and paraganglioma (PGL) are rare neuroendocrine tumors in... | 21st November, 2009
| Department of Pediatrics, University of Mississippi Medical Center,
| Pediatr Blood Cancer. 2009 Nov 19.
DOI Direct Link |
Expression of Reg IV and Hath1 in neuroendocrine neoplasms.
Reg IV (RELP), a Regenerating protein family member, is constitutively... | 20th November, 2009
| Department of Pathology, Haartman Institute, University of Helsinki,
| Histol Histopathol. 2010 Jan;25(1):63-72.
|
ZM447439, a Novel Promising Aurora Kinase Inhibitor, Provokes Antiproliferative and Proapoptotic Effects Alone and in Combination with Bio- and Chemotherapeutic Agents in Gastroenteropancreatic Neuroendocrine Tumor Cell Lines.
Background: Therapeutic approaches to gastroenteropancreatic... | 20th November, 2009
| Gastroenterologie/Infektiologie/Rheumatologie, Medizinische Klinik I,
| Neuroendocrinology. 2009 Nov 14.
DOI Direct Link |
Pancreatic Endocrine Tumors: Expression Profiling Evidences a Role for AKT-mTOR Pathway.
PURPOSE: We investigated the global gene expression in a large panel of... | 18th November, 2009
| Departments of Pathology and Surgical and Gastroenterological Sciences,
| J Clin Oncol. 2009 Nov 16.
DOI Direct Link |
Carcinoid tumors and small-cell carcinomas of the gallbladder and extrahepatic bile ducts: a comparative study based on 221 cases from the Surveillance, Epidemiology, and End Results Program.
Primary neuroendocrine tumors of the gallbladder (GB) and extrahepatic... | 18th November, 2009
| Instituto Nacional de Ciencias Medicas y Nutricion, CP 14000 Mexico City,
| Ann Diagn Pathol. 2009 Dec;13(6):378-83.
DOI Direct Link |
→View more research publications. |
Press Releases About Neuroendocrine Tumors:
|
 |
| AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer |
24th November, 2009 |
AETERNA ZENTARIS INC. |
Primary efficacy endpoint has been met for patients with advanced-stage
or recurrent endometrial cancer
QUEBEC CITY, Nov. 24 /PRNewswire-FirstCall/ - AEterna Zentaris Inc. (NASDAQ: AEZS;
|
| Scientific Presentations at 2009 ASTRO Meeting Highlight RapidArc(R) Radiotherapy Technology from Varian Medical Systems |
10th November, 2009 |
Varian Medical Systems, Inc. |
CHICAGO, Nov. 10 /PRNewswire-FirstCall/ -- Clinicians using RapidArc® radiotherapy technology for fast, precise, non-invasive cancer treatments have found that they are able to substantially reduce
|
| AEterna Zentaris Announces Positive Preliminary Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Ovarian Cancer |
2nd November, 2009 |
AETERNA ZENTARIS INC. |
Preliminary evaluation after completion of treatment phase shows that
primary efficacy endpoint has been met for patients with advanced-stage
platinum-resistant, taxane-pretreated ovarian
|
| Reportlinker Adds Monoclonal Antibodies: Pipeline Analysis and Competitive Assessment |
26th October, 2009 |
Reportlinker |
-- A focus on "engineered" antibodies
Monoclonal Antibodies: Pipeline Analysis and Competitive Assessment reviews the broad drug development effort that is focused on bringing
|
| Ascenta Therapeutics Announces Presentation of Results From a Dose-Ranging Study of AT-101 With Standard Therapy in Patients With Glioblastoma Multiforme |
26th October, 2009 |
Ascenta Therapeutics, Inc. |
MALVERN, Pa., Oct. 26 /PRNewswire/ -- Ascenta Therapeutics announced today that encouraging results from a Phase I dose-escalation study of two combination therapy regimens containing AT-101, an oral,
|
Companies working in the area of Neuroendocrine Tumors from Bioportfolio's Biocorporate database : | |
| Company Name | |
Tercica, Inc., based in Brisbane, Calif., is a biopharmaceutical company committed to improving endocrine health. We are helping patients by partnering with the scientific and medical community to...
www.tercica.com/ View full profile
| |
Molecular Insight Pharmaceuticals, Inc. is focused on the research, development and commercialization of innovative molecular imaging pharmaceuticals and targeted radiotherapeutics to diagnose, treat...
www.molecularinsight.com/ View full profile
| |
BioPortfolio Ltd. offers e-mail and postal lists for Neuroendocrine Tumors scientists - we have details of around 291 individuals working on Neuroendocrine Tumors .
This page has been viewed 461 times
Recent Search Terms used to find this page: neuroendocrine glioma tumors | neuroendocrine tumour, e-medicine | neuroendocrine tumors | neuroendocrine tumors news | neuroendocrine tumors of pancreas | neuroendrocrine 2009 | Predicting neuroendocrine tumor (carcinoid) neoplasia using gene expression profiling and supervised machine learning | video of pancreas neuroendocrine tumor | any new news on neuro endocrine tumors | .
Browse BioPortfolio's InDepth service - alphabetically:
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
or by Most Publications, recently searched for, or
most viewed.
Search for Neuroendocrine Tumors across BioPortfolio, or for Neuroendocrine Tumors Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH.
Thumbshots from Thumbshots.org
|
